References in periodicals archive ?
In fact, published research confirms that chronotherapy is associated with improved outcomes, including reduced toxicity and improved survival.
The researchers concluded that 51 percent of the chronotherapy group responded well to their treatment, compared with 29 percent of the standard treatment group.
25, 2011 /PRNewswire-USNewswire/ -- A new program in psychiatric chronotherapy that provides the quickest methods to relieve depression is now available at Northwestern Memorial Hospital.
I couldn't believe how good I felt throughout my chronotherapy treatments," Gerry told me later.
1998) successfully treated an 8-year-old girl with severe ID and autism and a fragmented sleep-wake pattern and reduced total sleep using chronotherapy together with regular daytime activities.
Targeting pathophysiological rhythms: prednisone chronotherapy shows sustained efficacy in rheumatoid arthritis.
Safety data for low-dose glucocorticoid chronotherapy of rheumatoid arthritis with 5 mg modified-release (MR) prednisone in a randomized, double-blind, placebo-controlled trial
historical developments in RA chronotherapy (delivery of nonsteroid anti-inflammatory drugs [NSAIDs], synthetic glucocorticosteroids, and other medications with reference to the 24-hour pattern in cytokine biomarkers of RA disease activity and symptoms severity).
a late-stage biopharmaceutical company focused on the development and commercialization of innovative medicines for pain-related diseases and chronic inflammation, today announced interim results from a pilot clinical study showing that LODOTRA[R] (modified release prednisone tablet) chronotherapy may improve asthma control and asthma-related quality of life when added to standard asthma therapy in patients with severe nocturnal asthma.
Mistral intends to develop branded oral drug delivery products offering added clinical value through improved pharmacokinetic profile or chronotherapy concept.
Despite the evidence, few physicians incorporate chronotherapy in their clinical practice.
MILAN, Italy -- MILAN, Italy, March 13 /PRNewswire/ -- Eurand today announced that the US Food and Drug Administration (FDA) has granted final marketing clearance to Reliant Pharmaceuticals LLC for InnoPran XL(TM) (propranolol hydrochloride) Extended Release capsules, a once-a-day chronotherapy, which utilizes Eurand's novel Diffucaps(R) technology.